| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 147391-80-8 | b-D-Xylopyranoside, (3b,4b,5a,15b,24S)-4,15,24-trihydroxycholesta-7,9(11)-dien-3-yl2-O-methyl- (9CI); Cholestane,b-D-xylopyranoside deriv.; Moniloside B |  | C33H54O8 | 詳情 | 供應商 | |
| 151589-17-2 | b-L-Galactopyranoside, (1b,3b,5a,25R)-3-hydroxyspirostan-1-yl 6-deoxy- (9CI); Spiro[8H-naphth[2',1':4,5]indeno[2,1-b]furan-8,2'-[2H]pyran],b-L-galactopyranoside deriv.; Spirostan, b-L-galactopyranoside deriv. |  | C33H54O8 | 詳情 | 供應商 | |
| 14835-43-9 | b-D-Glucopyranoside, (3b,5b,25S)-spirostan-3-yl; 5b-Spirostan, 3b-(b-D-glucopyranosyloxy)-, (25S)- (8CI); Asparagoside A; Sarsasapogenin 3-O-b-D-glucopyranoside; Sarsasapogenin glucoside |  | C33H54O8 | 詳情 | 供應商 | |
| 31556-81-7 | Monamycin G2 (8CI,9CI); 2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazacyclooctadecine,cyclic peptide deriv.; D-Isoleucine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone; N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-isoleucinep-lactone |  | C33H54ClN7O8 | 詳情 | 供應商 | |
| 31556-82-8 | Monamycin G3 (8CI,9CI); 2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazacyclooctadecine,cyclic peptide deriv.; D-Valine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone; N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-valinep-lactone |  | C33H54ClN7O8 | 詳情 | 供應商 |